Dyne Therapeutics Inc DYN
NASDAQ · United States · Health Technology
$15.82-0.29 (-1.80%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-29 | -1.08 | -0.75 | -44.2% | $0 | — | -0.7%$25.90→$25.73 |
| Q1 2026 | 2026-05-11 | -0.73 | -0.78 | +6.4% | — | — | +4.3%$17.61→$18.37 |
| Q4 2025 | 2026-03-02 | -0.73 | -0.76 | +3.9% | — | — | -6.5%$15.62→$14.60 |
| Q3 2025 | 2025-11-05 | -0.76 | -0.81 | +6.2% | — | — | -15.4%$21.52→$18.20 |
| Q2 2025 | 2025-07-28 | -0.97 | -0.93 | -4.3% | — | — | — |
| Q4 2024 | 2025-02-27 | -0.88 | -0.91 | +3.3% | — | — | — |
| Q3 2024 | 2024-11-12 | -0.96 | -0.71 | -35.2% | — | — | — |
| Q2 2024 | 2024-08-12 | -0.70 | -0.72 | +2.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.